HER2-low Breast Cancer: Salivary Metabolic Features and Therapeutic Perspectives
Thus, patients with HER2-low breast cancer status had their own characteristic features in the course of the disease, immune response and metabolic activity. Understanding the features of metabolic processes in the HER2-low subgroup can help identify new therapeutic targets for this group of patients.
Authors
- Lyudmila V. Bel’skaya (ORCID: https://orcid.org/0000-0002-6147-4854)
Institutions
- Omsk State Pedagogical University (RU)
Publication Details
- Journal
- Frontiers in Bioscience-Scholar
- Published
- 2025-06-24
- DOI
- https://doi.org/10.31083/fbs36652
- Citations
- 2
- Primary Topic
- Salivary Gland Disorders and Functions
- Type
- article
- Field-Weighted Citation Impact
- 2.33
Funders
- Russian Science Foundation